Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 209

1.

AIDS malignancies in the era of highly active antiretroviral therapy.

Gates AE, Kaplan LD.

Oncology (Williston Park). 2002 May;16(5):657-65; discussion 665, 668-70. Review.

2.

AIDS malignancies in the era of highly active antiretroviral therapy.

Gates AE, Kaplan LD.

Oncology (Williston Park). 2002 Apr;16(4):441-51, 456, 459. Review.

3.

[Epidemiology of HIV-associated malignancies].

Launay O, Guillevin L.

Bull Cancer. 2003 May;90(5):387-92. Review. French.

PMID:
12850760
4.

The epidemiology of acquired immunodeficiency syndrome malignancies.

Goedert JJ.

Semin Oncol. 2000 Aug;27(4):390-401. Review.

PMID:
10950365
5.

Therapeutic approaches to AIDS-related malignancies.

Berretta M, Cinelli R, Martellotta F, Spina M, Vaccher E, Tirelli U.

Oncogene. 2003 Sep 29;22(42):6646-59. Review.

PMID:
14528290
7.

[AIDS associated cancers in the era of highly active antiretroviral therapy (HAART)].

Tserenpuntsag B, Kołacińska A, Jabłonowska E.

Przegl Epidemiol. 2007;61(3):529-34. Review. Polish.

PMID:
18069390
9.

AIDS-related cancers in the era of highly active antiretroviral therapy.

Biggar RJ.

Oncology (Williston Park). 2001 Apr;15(4):439-48; discussion 448-9. Review.

10.

AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.

Cheung MC, Pantanowitz L, Dezube BJ.

Oncologist. 2005 Jun-Jul;10(6):412-26. Review.

11.

Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.

International Collaboration on HIV and Cancer.

J Natl Cancer Inst. 2000 Nov 15;92(22):1823-30.

12.

Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review.

Cobucci RN, Lima PH, de Souza PC, Costa VV, Cornetta Mda C, Fernandes JV, Gonçalves AK.

J Infect Public Health. 2015 Jan-Feb;8(1):1-10. doi: 10.1016/j.jiph.2014.08.003. Epub 2014 Oct 5. Review.

PMID:
25294086
13.

AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy.

Bower M, Palmieri C, Dhillon T.

Curr Opin Infect Dis. 2006 Feb;19(1):14-9. Review.

PMID:
16374212
15.

Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART).

Chow KU, Mitrou PS, Geduldig K, Helm EB, Hoelzer D, Brodt HR.

Leuk Lymphoma. 2001 Mar;41(1-2):105-16.

PMID:
11342362
16.

Less cancer--or more--with HAART? Or, reflections on a late opus.

Mascolini M.

J Int Assoc Physicians AIDS Care. 1998 Jun;4(6):12-22.

PMID:
11365531
17.

Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.

Robotin MC, Law MG, Milliken S, Goldstein D, Garsia RJ, Dolan GM, Kaldor JM, Grulich AE.

HIV Med. 2004 Sep;5(5):377-84.

18.

AIDS and non-Hodgkin's lymphoma. Experience at an oncological center in Mexico.

Cornejo-Juárez P, Volkow-Fernández P, Avilés-Salas A, Calderón-Flores E.

Rev Invest Clin. 2008 Sep-Oct;60(5):375-81.

PMID:
19227434
19.

The effect of HAART and calendar period on Kaposi's sarcoma and non-Hodgkin lymphoma: results of a match between an AIDS and cancer registry.

Pipkin S, Scheer S, Okeigwe I, Schwarcz S, Harris DH, Hessol NA.

AIDS. 2011 Feb 20;25(4):463-71. doi: 10.1097/QAD.0b013e32834344e6.

20.

Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007.

Seaberg EC, Wiley D, Martínez-Maza O, Chmiel JS, Kingsley L, Tang Y, Margolick JB, Jacobson LP; Multicenter AIDS Cohort Study (MACS).

Cancer. 2010 Dec 1;116(23):5507-16. doi: 10.1002/cncr.25530. Epub 2010 Jul 29.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk